期刊文献+

FOLFOX_4方案治疗晚期结直肠癌的临床观察 被引量:3

Clinical observation of FOLFOX_4 proctocol for advanced colorectal cancer
下载PDF
导出
摘要 目的观察FOLFOX4方案治疗晚期结直肠癌的临床疗效及不良反应。方法采用草酸铂(OXA)85mg/m2,静脉滴注2h,第1天;亚叶酸钙(LV)200mg/m2静脉滴注2h,第1~2天;5-氟尿嘧啶(5-FU)400mg/m2,第1~2天静脉注射;5-FU600mg/m2持续静脉滴注(22h)第1~2天的方案治疗30例晚期结肠癌患者。2周为1周期,重复4周期后间隔1个月评价疗效。结果全组30例,CR1例(3.3%),PR10例(33.3%),SD9例(30.0%),PD10例(33.3%),总有效率为36.6%。不良反应主要为神经毒性、胃肠道反应和骨髓抑制,多呈Ⅰ~Ⅱ度,可耐受。结论FOLFOX4方案治疗晚期结肠癌安全有效,可作为晚期结肠癌的首选化疗方案。 Objective To evaluate the efficacy and toxicity of the protocol of FOLFOX4 for advanced colorectal cancer. Methods 30 patients received FOLFOX4 [ Oxaliplatin 85 mg/m^2 as a 2-hour infusion on dayl and a 2-hour infusion of LV 200 rag/( m · d) followed by 5-FU bolus 400 mg/( m · d) and 22-hour infusion (600 mg/m · d)for 2 consecutive days every two weeks]. Four courses were carried out with an interval of one month. Results 30 patients:CR 1 case(3.3%),PR 10 cases(33.3%),SD 9 cases(30%),PD 10 cases (33.3%). The overall response rate was 36.6%. The major toxicities were neurotoxicity, suppression of bone marrow, gastrointestinal toxicity and most of which Ⅰ -Ⅱgrad. Conclusion The effective of FOLFOX4 which seems beneficial as first-line therapy in advanced colorectal cancer has a high effective rate with acceptable tox- icity.
出处 《中国现代药物应用》 2008年第4期14-15,共2页 Chinese Journal of Modern Drug Application
关键词 晚期结肠癌 化学疗法 FOLFOX4 Advanced colorectal cancer Chemotherapy FOLFOX4
  • 相关文献

参考文献8

  • 1张小田.进展期结直肠癌的内科治疗进展[J].癌症进展,2007,5(1):35-40. 被引量:18
  • 2周建凤,陈书长.FOLFOX4方案一线治疗晚期大肠癌近期疗效分析[J].癌症进展,2006,4(5):452-455. 被引量:6
  • 3吴东平,吕杰青,陶锋,王建芳,王松祥.FOLFOX4方案治疗晚期结直肠癌的临床观察[J].肿瘤研究与临床,2006,18(4):255-257. 被引量:6
  • 4[4]De Gramont A,Louvet C,Andre T,et al.Modulation of 5-fluorouracil with folinic acid in advanced colorectal Cancers.Groupe d 'etude et de recherehe sur les cancers de I' Ovaire et digestifs(GERCOD).Rev Med Interne,1997,18(suppl 4):372.
  • 5[5]Raymond E,Buquet-Fagot C,et al.Antitumor activity of oxaliplatin in Combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human Colon,breast,and ovarian cancers.Anticancer Brugs,1997,8:876.
  • 6[6]Kouroussis C,Souglakos J,Kakolyris S,et al.Oxaliplatin in Combination with infusional 5-fluorouracil and leucovorin every 2 weeks as first-line treatment in patients with advanced Colorectal Cancer:A phase Ⅱ Study.Oncology,2001,61(1):36.
  • 7[7]Carrato A,Gallego J,Diaz-Rubio E.Oxaliplatin:results in Colorectal Carcinoma.Crit Rev Oncol Hematol,2002,44(1):29.
  • 8应杰儿,钟海均,冯海洋.FOLFOX4方案治疗晚期大肠癌的临床观察[J].肿瘤防治杂志,2005,12(18):1423-1424. 被引量:28

二级参考文献48

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2陆仰东.国产奥沙利铂为主的联合化疗治疗51例晚期大肠癌疗效观察[J].中国肿瘤临床,2004,31(24):1401-1403. 被引量:5
  • 3[1]Raymond E,Buquet-Fagot C,et al.Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon,breast,and ovarian cancers.Anticancer Drugs,1997,8:876
  • 4[2]De Gramont,Figer A,et al.Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.J Clin Oncol,2000,18:2938
  • 5[3]Goldberg RM,Sargent DJ,et al.A randomized controlled trial of fluorouracil plus leucovorin,irinotecan,and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.J Clin Oncol,2004,22:23
  • 6[4]Delaunoit T,Alberts SR,Sargent DJ,et al.Chemotherapy permits resection of metastatic colorectal cancer:Experience from Intergroup N9741.Ann Oncol,2005,16 (3):425
  • 7[5]Alberts SR,Horvath WL,Sternfeld WC,et al.Oxaliplatin,fluorouracil,and leucovorin for patients with unresectable liveronly metastases from colorectal cancer:A North Central Cancer Treatment Group phase Ⅱ study.J Clin Oncol,2005,23:9243-9249.
  • 8[1]de Gramont A,Louvet C,Andre T,et al.Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers.Grouped 'etude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD).Rev Med Interne,1997,18 Suppl 4:372S
  • 9[2]Van Cutsem E,Findlay M,Osterwalder B,et al.Capecitabine,an oral fluoropyrimidine carbamate with substantial activity in advanced colorectal cancer:Results of a randomized phase Ⅱ study.J Clin Oncol,2000,18 (6):1337
  • 10[3]Cvitkovic E,Bekradda M.Oxaliplatin:A new therapeutic option in colorectal cancer.Semin Oncol,1999,26(6):647

共引文献52

同被引文献19

引证文献3

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部